drugset / Trial / NCT01102491

Additional Anti-emetic Effect of Ramosetron Prophylaxis After Total Knee Arthroplasty

NCT01102491

Phase 4 Completed 153 enrolled Seoul National University Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

The purposes of this study are to document the antiemetic efficacy of multimodal antiemetic protocol in patient after Total Knee Arthroplasty using regional anesthesia, midazolam \& propofol, hydration \& oxygen supplement, preemptive \& multimodal contemporary pain management and to determine whether Ramosetron prophylaxis would provide additional antiemetic effect on this protocol. We hypothesized that the incidence of Postoperative nausea and vomiting during multimodal antiemetic protocol would be lower than Apfel's expected postoperative nausea and vomiting incidence. It was also hypothesized that Ramosetron prophylaxis would provide additional antiemetic effect.

Timeline

Start
2009-09
Primary completion
2010-02
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramosetron Small molecule 0.3 mg Intravenous

Indications